Spark Investment Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-40,200
Closed -$9.4M 402
2019
Q2
$9.4M Buy
+40,200
New +$9.28M 0.65% 38
2018
Q4
Sell
-29,400
Closed -$10.4M 673
2018
Q3
$10.4M Sell
29,400
-12,900
-30% -$4.44M 0.59% 28
2018
Q2
$12.3M Buy
42,300
+2,200
+5% +$619K 0.72% 21
2018
Q1
$11M Buy
40,100
+4,600
+13% +$1.43M 0.7% 25
2017
Q4
$11.3M Hold
35,500
0.61% 33
2017
Q3
$11.1M Buy
35,500
+2,500
+8% +$740K 0.6% 26
2017
Q2
$8.95M Hold
33,000
0.55% 31
2017
Q1
$9.02M Hold
33,000
0.57% 21
2016
Q4
$9.36M Buy
33,000
+10,500
+47% +$3.11M 0.77% 7
2016
Q3
$7.04M Hold
22,500
0.57% 24
2016
Q2
$5.44M Buy
22,500
+17,600
+359% +$4.64M 0.51% 33
2016
Q1
$1.27M Buy
+4,900
New +$1.29M 0.13% 254
2015
Q4
Sell
-2,400
Closed -$698K 754
2015
Q3
$698K Hold
2,400
0.09% 315
2015
Q2
$969K Buy
+2,400
New +$963K 0.14% 224
2014
Q4
Sell
-6,900
Closed -$2.28M 700
2014
Q3
$2.28M Hold
6,900
0.34% 85
2014
Q2
$2.17M Hold
6,900
0.32% 92
2014
Q1
$2.11M Sell
6,900
-2,400
-26% -$762K 0.33% 87
2013
Q4
$2.6M Buy
9,300
+7,200
+343% +$1.86M 0.45% 44
2013
Q3
$505K Hold
2,100
0.12% 256
2013
Q2
$451K Buy
+2,100
New +$449K 0.12% 216

Other funds holding BIIB

Spark Investment Management's BIIB Position: Q3 2019 in Review

Spark Investment Management sold out of Biogen (BIIB) in Q3 2019, closing a stake of 40,200 shares — an estimated $9.4M sold.

Spark Investment Management first reported a position in BIIB in Q2 2013 and held it in 20 quarters. The position peaked at $12.3M in Q2 2018. 988 funds tracked by Wall St. Rank hold BIIB as of Q3 2019.

  • Spark Investment Management reported no remaining Biogen position as of Q3 2019 after selling out during the quarter.
  • Spark Investment Management sold 40,200 Biogen shares in Q3 2019, an estimated $9.4M.
  • Spark Investment Management first reported a position in Biogen in Q2 2013 and held it in 20 quarters.
  • Spark Investment Management's Biogen position peaked at $12.3M in Q2 2018.
  • 988 funds tracked by Wall St. Rank held Biogen as of Q3 2019.

Based on Spark Investment Management's 13F filing for Q3 2019, filed 12 Nov 2019.